As of May 2022 Merck has a market cap of $236.57 Billion. This makes Merck the world's 34th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to mesure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2022 | $236.57 B | 22.2% |
2021 | $193.58 B | -6.46% |
2020 | $206.95 B | -10.38% |
2019 | $230.92 B | 16.57% |
2018 | $198.09 B | 29.22% |
2017 | $153.30 B | -5.55% |
2016 | $162.31 B | 10.49% |
2015 | $146.89 B | -8.86% |
2014 | $161.17 B | 10% |
2013 | $146.52 B | 18.25% |
2012 | $123.91 B | 7.84% |
2011 | $114.90 B | 3.45% |
2010 | $111.07 B | -2.2% |
2009 | $113.57 B | 76.71% |
2008 | $64.27 B | -49.09% |
2007 | $126.24 B | 33.57% |
2006 | $94.51 B | 36.18% |
2005 | $69.40 B | -2.22% |
2004 | $70.98 B | -30.84% |
2003 | $102.64 B | -19.46% |
2002 | $127.44 B | -6.04% |
2001 | $135.63 B |
On May 20th, 2022 the market cap of Merck was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
![]() Johnson & Johnson JNJ | $465.70 B | 96.86% | ๐บ๐ธ USA |
![]() Novartis NVS | $197.85 B | -16.37% | ๐จ๐ญ Switzerland |
![]() Pfizer PFE | $294.40 B | 24.45% | ๐บ๐ธ USA |
![]() Abbott Laboratories ABT | $198.27 B | -16.19% | ๐บ๐ธ USA |
![]() Eli Lilly LLY | $283.95 B | 20.03% | ๐บ๐ธ USA |
![]() Amgen AMGN | $132.21 B | -44.11% | ๐บ๐ธ USA |
![]() Sanofi SNY | $135.85 B | -42.57% | ๐ซ๐ท France |
![]() Bristol-Myers Squibb BMY | $162.21 B | -31.43% | ๐บ๐ธ USA |
![]() GlaxoSmithKline GSK | $114.83 B | -51.46% | ๐ฌ๐ง UK |
![]() Teva Pharmaceutical Industries TEVA | $9.40 B | -96.02% | ๐ฎ๐ฑ Israel |